OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
An imidazo[1,2-a]pyridine-pyridine derivative potently inhibits FLT3-ITD and FLT3-ITD secondary mutants, including gilteritinib-resistant FLT3-ITD/F691L
Xiuqi Wang, Rosa Anna DeFilippis, Tsigereda Weldemichael, et al.
European Journal of Medicinal Chemistry (2023) Vol. 264, pp. 115977-115977
Closed Access | Times Cited: 5
Xiuqi Wang, Rosa Anna DeFilippis, Tsigereda Weldemichael, et al.
European Journal of Medicinal Chemistry (2023) Vol. 264, pp. 115977-115977
Closed Access | Times Cited: 5
Showing 5 citing articles:
Overcoming Secondary Mutations of Type II Kinase Inhibitors
Xiuqi Wang, Rosa Anna DeFilippis, Wei Yan, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 12, pp. 9776-9788
Closed Access | Times Cited: 3
Xiuqi Wang, Rosa Anna DeFilippis, Wei Yan, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 12, pp. 9776-9788
Closed Access | Times Cited: 3
Discovery of FLT3-targeting PROTACs with potent antiproliferative activity against acute myeloid leukemia cells harboring FLT3 mutations
Zhijie Wang, Xun Lu, Canlin Liu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116237-116237
Closed Access | Times Cited: 2
Zhijie Wang, Xun Lu, Canlin Liu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116237-116237
Closed Access | Times Cited: 2
Current progress in the synthesis of imidazoles and their derivatives via the use of green tools
Debasree Saha, Chhanda Mukhopadhyay
Heterocyclic Communications (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 2
Debasree Saha, Chhanda Mukhopadhyay
Heterocyclic Communications (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 2
New strategies to hit hematological cancers
Marilia Barreca, Francesco Bertoni, Paola Barraja
European Journal of Medicinal Chemistry (2024) Vol. 270, pp. 116350-116350
Closed Access
Marilia Barreca, Francesco Bertoni, Paola Barraja
European Journal of Medicinal Chemistry (2024) Vol. 270, pp. 116350-116350
Closed Access
N-(3-Methoxyphenyl)-6-(7-(1-methyl-1H-pyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl)pyridin-2-amine is an inhibitor of the FLT3-ITD and BCR-ABL pathways, and potently inhibits FLT3-ITD/D835Y and FLT3-ITD/F691L secondary mutants
Xiuqi Wang, Rosa Anna DeFilippis, YuetâKin Leung, et al.
Bioorganic Chemistry (2023) Vol. 143, pp. 106966-106966
Open Access | Times Cited: 1
Xiuqi Wang, Rosa Anna DeFilippis, YuetâKin Leung, et al.
Bioorganic Chemistry (2023) Vol. 143, pp. 106966-106966
Open Access | Times Cited: 1
